Targeting c-FLIP in cancer.

Abstract : Cellular-FLICE inhibitory protein (c-FLIP) is a key anti-apoptotic regulator that inhibits cell death mediated by the death receptors Fas, DR4, DR5, and TNF-R1. Three splice variants of c-FLIP function at the DISC level by blocking the processing and activation of procaspase-8 and -10. Overexpression of c-FLIP has been identified in many different tumour types, and its downregulation in vitro has been shown to restore apoptosis mediated by CD95L and TRAIL. c-FLIP therefore represents a promising target for cancer therapy. This review focuses on the molecular mechanisms that control c-FLIP expression and current research into inhibitors of the protein. Increasing evidence supports the investigation of c-FLIP as a therapeutic target to restore an apoptotic response in cancer cells.
Type de document :
Article dans une revue
Cancer Letters, Elsevier, 2013, 332 (2), pp.141-50. 〈10.1016/j.canlet.2010.10.009〉
Liste complète des métadonnées
Contributeur : Olivier Micheau <>
Soumis le : lundi 15 novembre 2010 - 10:36:41
Dernière modification le : vendredi 8 juin 2018 - 14:50:12
Document(s) archivé(s) le : vendredi 2 décembre 2016 - 00:27:01


Fichiers produits par l'(les) auteur(s)




Sarah Shirley, Olivier Micheau. Targeting c-FLIP in cancer.. Cancer Letters, Elsevier, 2013, 332 (2), pp.141-50. 〈10.1016/j.canlet.2010.10.009〉. 〈inserm-00525448〉



Consultations de la notice


Téléchargements de fichiers